San Diego-based Turquoise Health, a free search engine that lets patients compare hospital prices for US medical procedures, raises a $20M Series A led by a16z
Michael Schroeder / MedCity News :
Context & Ripple Effects
Turquoise Health's $20M Series A, led by a16z, funds a free search engine where patients compare hospital prices for US procedures — a bet that procedure-price lookup can become a standalone business rather than a hospital-side compliance feature. The arc validates quickly: the company later raised a $40M Series C led by Oak HC/FT, bringing total funding to $95.3M and expanding from search into a broader pricing-and-payments platform.
The raise lands amid a wave of venture money aimed at making healthcare prices comparable: weeks earlier, Waltz Health emerged from stealth with a $35.4M GV-led Series A for a tool that lets patients compare drug prices across pharmacies and marketplaces (Waltz's drug-price search), while Vezeeta's earlier $40M round showed the medical-search playbook working internationally.
First-order effects
- Patients gain a no-cost way to compare hospital prices for specific procedures before booking, shifting some pre-treatment research away from insurer tools and hospital billing offices.
- a16z's lead gives Turquoise Health capital and credibility to scale its database coverage beyond early markets, pressuring hospitals whose negotiated rates were previously opaque.
Second-order effects
- Hospitals competing on discoverable prices now face shoppers who arrive with cross-facility comparisons, forcing rate and packaging decisions toward what the search layer surfaces.
- Adjacent players follow the same template — Waltz Health's pharmacy-comparison launch shows investors funding price-search layers segment by segment, splitting the 'healthcare shopping' surface between procedures and drugs.
Third-order effects
- If the pattern holds, healthcare purchasing consolidates around third-party search and payments intermediaries that sit between patient and provider, with Turquoise Health's own expansion from free search into a full pricing-and-payments platform as the template.
- Sustained multi-stage funding (Series A through a $95.3M-total Series C) suggests price transparency is becoming durable infrastructure rather than a regulatory afterthought, raising the bar for providers who treat published rates as a checkbox.
The trend: Venture capital is building consumer-facing price-comparison layers across healthcare — procedures, drugs, and provider search — turning once-opaque pricing into a searchable, monetizable market.